CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 103 filers reported holding CONSTELLATION PHARMCETICLS I in Q4 2019. The put-call ratio across all filers is 0.31 and the average weighting 2.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $222,000 | -17.5% | 9,500 | +1.8% | 0.09% | -16.1% |
| Q4 2020 | $269,000 | +48.6% | 9,331 | +4.4% | 0.11% | +17.9% |
| Q3 2020 | $181,000 | -40.7% | 8,940 | -12.0% | 0.10% | -34.0% |
| Q2 2020 | $305,000 | +6.3% | 10,157 | +11.3% | 0.14% | +22.0% |
| Q1 2020 | $287,000 | -41.8% | 9,122 | -12.8% | 0.12% | +45.7% |
| Q4 2019 | $493,000 | – | 10,465 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP, LLC | 3,034,083 | $37,259,000 | 42.17% |
| Svennilson Peter | 4,677,939 | $57,446,000 | 16.42% |
| VHCP Management II, LLC | 726,677 | $8,924,000 | 2.81% |
| Casdin Capital, LLC | 1,523,960 | $18,714,229,000 | 1.75% |
| P.A.W. CAPITAL CORP | 120,000 | $1,474,000 | 1.59% |
| Cormorant Asset Management, LP | 1,271,685 | $15,616,000 | 0.90% |
| VHCP Management III, LLC | 66,667 | $819,000 | 0.38% |
| Orbimed Advisors | 835,842 | $10,264,000 | 0.16% |
| Hillhouse Capital Management | 317,921 | $3,904,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 183,600 | $2,255,000 | 0.08% |